Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults
Tóm tắt
Từ khóa
Tài liệu tham khảo
Afshari, 2012, A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis, International Journal of Neuroscience, 122, 60, 10.3109/00207454.2011.626908
Freitag, 2002, A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis, Neurology, 58, 1652, 10.1212/WNL.58.11.1652
Hering, 1992, Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo, Cephalalgia, 12, 81, 10.1046/j.1468-2982.1992.1202081.x
Jensen, 1994, Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study, Neurology, 44, 647, 10.1212/WNL.44.4.647
Kaniecki, 1997, A comparison of divalproex with propanolol and placebo for the prophylaxis of migraine without aura, Archives of Neurology, 54, 1141, 10.1001/archneur.1997.00550210071015
Kinze, 2001, Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open-label study, Headache, 41, 774, 10.1046/j.1526-4610.2001.01142.x
Klapper, 1997, Divalproex sodium in migraine prophylaxis: a dose-controlled study, Cephalalgia, 17, 103, 10.1046/j.1468-2982.1997.1702103.x
Mathew, 1995, Migraine prophylaxis with divalproex, Archives of Neurology, 52, 281, 10.1001/archneur.1995.00540270077022
Mitsikostas, 1997, Valproate versus flunarizine in migraine prophylaxis: a randomized, double-open, clinical trial, Functional Neurology, 12, 267
Shaygannejad, 2006, Comparison of the effect of topiramate and sodium valproate in migraine prevention: a randomized blinded crossover study, Headache, 46, 642, 10.1111/j.1526-4610.2006.00413.x
Arnold, 1998, Valproic acid in the prophylactic treatment of migraine, Nervenarzt, 69, 913, 10.1007/s001150050364
Bartolini, 2005, Efficacy of topiramate and valproate in chronic migraine, Clinical Neuropharmacology, 28, 277, 10.1097/01.wnf.0000192136.46145.44
Bavrasad, 2010, Assessment of the middle dose of topiramate in comparison with sodium valproate for migraine prophylaxis: a randomized double-blind study, International Journal of Pharmacology, 6, 670, 10.3923/ijp.2010.670.675
Blumenfeld, 2008, Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine, Headache, 48, 210, 10.1111/j.1526-4610.2007.00949.x
Cutrer, 2001, Antiepileptic drugs: how they work in headache, Headache, 41 Suppl 1, S3, 10.1046/j.1526-4610.2001.01154-2.x
Erdemoglu, 2000, Valproic acid in prophylaxis of refractory migraine, Acta Neurologica Scandinavica, 102, 354, 10.1034/j.1600-0404.2000.102006354.x
Fragoso, 2003, Low dose of sodium divalproate for the treatment of migraine, MedGenMed [electronic resource]: Medscape General Medicine, 5, 32
Ghose, 1998, Prophylactic sodium valproate therapy in patients with drug-resistant migraine, Methods & Findings in Experimental & Clinical Pharmacology, 20, 353, 10.1358/mf.1998.20.4.485692
Green, 2005, Effect of divalproex on metabolic parameters is dose related in migraine prophylaxis, Headache, 45, 1031, 10.1111/j.1526-4610.2005.05184.x
Keyvan, 2009, Comparison of treatment effect of sodium valproate, propranolol and tricyclic antidepressants in migraine, Pakistan Journal of Biological Sciences, 12, 1098, 10.3923/pjbs.2009.1098.1101
Klapper, 1994, An open label cross-over comparison of divalproex sodium and propanolol HCl in the prevention of migraine headaches, Headache Quarterly, 5, 50
Krymchantowski, 2011, Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective "real-world" study, Headache, 51, 554, 10.1111/j.1526-4610.2011.01868.x
Lenaerts, 1996, Sodium valproate in severe migraine and tension-type headache: an open study of long-term efficacy and correlation with blood levels, Acta Neurologica Belgica, 96, 126
Millan-Guerrero, 2007, Subcutaneous histamine versus sodium valproate in migraine prophylaxis: a randomized, controlled, double-blind study, European Journal of Neurology, 14, 1079, 10.1111/j.1468-1331.2007.01744.x
Rothrock, 1994, A differential response to treatment with divalproex sodium in patients with intractable headache, Cephalalgia, 14, 241, 10.1046/j.1468-2982.1994.014003241.x
Rothrock, 1997, Clinical studies of valproate for migraine prophylaxis, Cephalalgia, 17, 81, 10.1046/j.1468-2982.1997.1702081.x
Silberstein, 1993, The safety and efficacy of divalproex sodium in the prophylaxis of migraine headache: a multicenter, double-blind, placebo-controlled trial, Headache, 33, 264
Sørensen, 1988, Valproate: a new drug in migraine prophylaxis, Acta Neurologica Scandinavica, 78, 346, 10.1111/j.1600-0404.1988.tb03667.x
Togha, 2008, Cinnarizine in refractory migraine prophylaxis: Efficacy and tolerability. A comparison with sodium valproate, Journal of Headache & Pain, 9, 77, 10.1007/s10194-008-0013-2
Ad Hoc Committee on the Classification of Headache of the National Institute of Neurological Diseases and Blindness, 1962, Classification of headache, JAMA, 179, 717
Alderson P Green S Higgins JPT Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]; Appendix 5b In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd
Clarke, 1996, Economic and social impact of migraine, QJM, 89, 77, 10.1093/oxfordjournals.qjmed.a030141
Cutrer, 1997, Possible mechanisms of valproate in migraine prophylaxis, Cephalalgia, 17, 93, 10.1046/j.1468-2982.1997.1702093.x
Dalkara, 2012, Recent progress in anticonvulsant drug research: strategies for anticonvulsant drug development and applications of antiepileptic drugs for non-epileptic central nervous system disorders, Current Topics in Medicinal Chemistry, 12, 1033, 10.2174/156802612800229215
Edmeads, 1993, Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey, Canadian Journal of Neurological Sciences, 20, 131, 10.1017/S0317167100047697
Edvinsson, 2010, New drugs in migraine treatment and prophylaxis: telcagepant and topiramate, Lancet, 376, 645, 10.1016/S0140-6736(10)60323-6
Evers, 2009, EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force, European Journal of Neurology, 16, 968, 10.1111/j.1468-1331.2009.02748.x
Vos, 2013, Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet, 380, 2163, 10.1016/S0140-6736(12)61729-2
Headache Classification Subcommittee of the International Headache Society, 2004, The International Classification of Headache Disorders: 2nd edition, Cephalalgia, 24 Suppl 1, 1
Headache Classification Committee of the International Headache Society, 1988, Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain, Cephalalgia, 8 Suppl 7, 1
Jadad, 1996, Assessing the quality of reports of randomized clinical trials: is blinding necessary?, Controlled Clinical Trials, 17, 1, 10.1016/0197-2456(95)00134-4
Linde, 2004, Propranolol for migraine prophylaxis, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003225.pub2
Linde, 2012, The cost of headache disorders in Europe: the Eurolight project, European Journal of Neurology, 19, 703, 10.1111/j.1468-1331.2011.03612.x
Linde, 2013, Topiramate for the prophylaxis of episodic migraine in adults, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD010610
Linde, 2013, Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD010611
Linde, 2013, Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD010609
Linde, 2013, Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD010608
McQuay, 1998, An Evidence-based Resource for Pain Relief
Mehuys, 2012, Self-medication of regular headache: a community pharmacy-based survey, European Journal of Neurology, 19, 1093, 10.1111/j.1468-1331.2012.03681.x
Morrell, 2003, Reproductive and metabolic disorders in women with epilepsy, Epilepsia, 44 Suppl 4, 11, 10.1046/j.1528-1157.44.s4.2.x
Olesen, 2006, New appendix criteria open for a broader concept of chronic migraine, Cephalalgia, 26, 742, 10.1111/j.1468-2982.2006.01172.x
Porter, 1992, Antiepileptic drugs, Basic and Clinical Pharmacology, 331
Reveiz-Herault, 2003, Effectiveness of flunarizine in the prophylaxis of migraine: a meta-analytical review of the literature, Revista de Neurologia, 36, 907, 10.33588/rn.3610.2002450
Silberstein, 2008, Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study, Neurology, 70, 548, 10.1212/01.wnl.0000297551.27191.70
Silberstein, 2012, Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society, Neurology, 78, 1337, 10.1212/WNL.0b013e3182535d20
Tfelt-Hansen, 2012, Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators, Cephalalgia, 32, 6, 10.1177/0333102411417901
Victor, 2003, Drugs for preventing migraine headaches in children, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD002761
Wiffen, 2010, Anticonvulsant drugs for acute and chronic pain, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001133.pub3
Chronicle, 2004, Anticonvulsant drugs for migraine prophylaxis, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003226.pub2